Lawrence Tian

Dr. Lawrence Tian is Chairman of Mevion Medical Systems Inc., Founder of YuanMing Capital, Founder and Chairman of China Entrepreneurs Forum and China-U.S. Business Leaders Roundtable. As a core organizer of various high-end meeting for entrepreneurs of both countries, Dr. Tian is an influential figure in the Sino-China business scene and has extensive social influence.

In 2015, Dr. Tian founded YuanMing Capital, a leading venture capital firm which focuses on the investment in pharmaceutical research and development, innovative medical devices and high-end medical services in both China and the United States. In 2018, YuanMing Capital and its partners completed acquisition of Mevion Medical Systems, Inc., a global leader in the field of compact proton therapy. Dr. Tian was appointed as Chairman of the company. Led by Mevion, the world’s leading compact proton system has developed into a mainstream technology for precision radiotherapy in the global scene. It is being applied in hospitals worldwide and will benefit thousands of cancer patients in China.

Prior to YuanMing, Dr. Tian has had successful career as a serial entrepreneur with a strong track record of success. In the financial markets, he founded China International Futures Co., Ltd. (CIFCO) in 1992. CIFCO grew into a leading brokerage firm and achieved the largest market share in China during his 15 years of chairmanship. He also co-founded Wumart Group in 1994, which is one of the earliest and biggest retailers in China and the largest supermarket chain in Northern China. Dr. Tian is a member of the Advisory Committee of All-China Federation of Industry and Commerce (ACFIC), Vice Chairman of Investment Committee of China Pharmaceutical Industry Research and Development Association, Vice Chairman of China Association of Medical Equipment, member of the Biotech Advisory Panel of the Stock Exchange of Hong Kong Limited. He obtained his master’s degree and doctoral degree in economics from Wuhan University. He received the China Economics Theory Innovation Award, China’s highest prize for economics.